Clara Franco-Jarava Selected Research

Clara Franco-Jarava Research Topics

2	Chagas Disease (American Trypanosomiasis) 06/2022 - 01/2020
2	Infections 01/2022 - 01/2021
2	Hereditary Complement Deficiency Diseases 01/2019 - 01/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Sjogren's Syndrome (Sjogren Syndrome) 11/2021
1	Disease Progression 05/2021
1	Malaria 01/2021
1	Birth Weight (Birth Weights) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	COVID-19 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Parasitemia 01/2020
1	Inflammation (Inflammations) 01/2018
1	Complement Factor I Deficiency 11/2017
1	Otitis Media 11/2017
1	Reinfection 01/2016
1	Non-alcoholic Fatty Liver Disease 01/2016

3	Interleukin-10 (Interleukin 10)IBA 05/2021 - 01/2020
3	CytokinesIBA 01/2021 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 11/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 11/2017
2	chemotactic factor inactivatorIBA 11/2017 - 01/2016
1	benzonidazole (benznidazole)IBA 06/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	VaccinesIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021
1	interleukin-21 (interleukin 21)IBA 11/2021
1	Interleukin-22 (IL-22)IBA 11/2021
1	Interleukin-18 (Interleukin 18)IBA 11/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Complement Factor I (C3b Inactivator)IBA 01/2016

1	Therapeutics 01/2021